Di Cera E
Department of Biochemistry and Molecular Biophysics, Washington University Medical School, St Louis, MO 63110, USA.
J Thromb Haemost. 2007 Jul;5 Suppl 1:196-202. doi: 10.1111/j.1538-7836.2007.02485.x.
Thrombin is a Na(+)-activated, allosteric serine protease that plays opposing functional roles in blood coagulation. Binding of Na(+) is the major driving force behind the procoagulant, prothrombotic and signaling functions of the enzyme, but is dispensable for cleavage of the anticoagulant protein C. This basic regulatory feature of thrombin has fostered the rational engineering of mutants with selectively compromised fibrinogen and PAR1 cleavage. The discovery of the Na(+) effect on thrombin interaction with substrates and the mapping of functional epitopes by Ala scanning mutagenesis have provided a rational and effective strategy for dissociating the procoagulant and anticoagulant activities of the enzyme. Thrombin mutants with selectively compromised activity toward fibrinogen and PAR1 are effective in vivo as anticoagulant and antithrombotic agents.
凝血酶是一种Na(+)激活的变构丝氨酸蛋白酶,在血液凝固过程中发挥着相反的功能作用。Na(+)的结合是该酶促凝血、促血栓形成和信号传导功能背后的主要驱动力,但对于抗凝血蛋白C的裂解来说并非必需。凝血酶的这一基本调节特性促进了对纤维蛋白原和PAR1裂解选择性受损的突变体的合理工程设计。通过丙氨酸扫描诱变发现Na(+)对凝血酶与底物相互作用的影响以及功能表位的定位,为分离该酶的促凝血和抗凝血活性提供了一种合理有效的策略。对纤维蛋白原和PAR1活性选择性受损的凝血酶突变体在体内作为抗凝血和抗血栓形成剂是有效的。